OWC Pharmaceutical Research Corp (OWCP)

[psmithy]

PROOF OWCP COLLABORATES WITH SHEBA:


"Deputy Director General Manager For Medical Research Affairs, Medical Research and Development Fund for Health Services Branch SHEBA, The Chaim Sheba Medical Center" along with signature from former OWCP CEO, Ziv Turner.

There's plenty of proof that OWCP and Sheba are collaborating.

Previous 8-K states Dr. Aviv Barzilai, Director of the Department of Dermatology - Chaim Sheba Medical Center, is leading the study.
www.otcmarkets.com/edgar/GetFilingHtml?FilingID=11781669

Quote:

On December 29, 2016, OWC Pharmaceutical Research Corp. (the “Registrant”), through its wholly-owned Israeli subsidiary, One World Cannabis Ltd. (‘OWC”), entered into a Research Agreement with Medical Research Infrastructure Development and Health Services Fund by Chaim Sheba Medical Center, a non-profit organization incorporated under the laws of the State of Israel (the “Fund”), a copy of which Research Agreement is attached as Exhibit 10.21. hereto.

Pursuant to the Research Agreement, the Fund shall perform a Phase I, double blind, randomized, placebo-controlled, maximal dose study (the “Study”) to determine the safety, tolerability of topical cream containing MGC (“Medical Grade Cannabis” or the “Study Drug”) in healthy volunteers, employing the services of Dr. Aviv Barzila(i), Director of the Department of Dermatology- Chaim Sheba Medical Center, Tel Hashomer, Israel, to lead the Study (the “Investigator”). The Study shall be conducted in compliance with the following, as defined in the Research Agreement: (1) the Protocol; (2) the Ministry Guidelines; (3) the instructions and terms specified in the Helsinki Committee’s approval; (4) the ICH-GCP; (5) the Helsinki Declarations; (6) the applicable laws, rules and regulations regulating such studies which are applicable in Israel (the “Applicable Laws”); and (7) written instructions and prescriptions issued by the OWC and governing the administration of the Study Drug.

The 8-K also includes the Research Agreement which is stamped and signed (pic below) by what appears to be Dr. Dror Harats with title "Deputy Director General Manager For Medical Research Affairs, Medical Research and Development Fund for Health Services Branch, The Chaim Sheba Medical Center" along with signature from former OWCP CEO, Ziv Turner.



I'd think that's proof enough that OWCP and Sheba are collaborating. Unless you also think this agreement is falsified.

And regarding the Multiple Myeloma research, why would Dr. Merav Leiba, who serves as the Head of Multiple Myeloma Outpatient Clinic and Multiple Myeloma Research Lab at Sheba's Hematology Institute, be a senior science advisor for OWCP -
http://www.bloomberg.com/research/stocks/people/person.asp?personId=325525470&privcapId=44468111